Alana Philips
Novo Nordisk, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Changing from a glargine-based insulin regimen to biphasic insulin aspart 30 in people with type 2 diabetes (#327)
1:00 PM
Alana Philips
ADS Clinical Poster Viewing
Patients and prescribers in type 2 diabetes reported on attitudes and behaviours towards irregular basal insulin dosing in Australia (#320)
1:00 PM
Margaret McGill
ADS Clinical Poster Viewing